Market revenue in 2023 | USD 152.1 million |
Market revenue in 2030 | USD 243.2 million |
Growth rate | 6.9% (CAGR from 2023 to 2030) |
Largest segment | Quantitative |
Fastest growing segment | Digital |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Quantitative, Digital, End-point |
Key market players worldwide | Abbott Laboratories, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, GE Aerospace, BioMerieux SA, Roche Holding AG ADR, Fluidigm Corporation |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to real time pcr, digital pcr, and end point pcr market will help companies and investors design strategic landscapes.
Quantitative was the largest segment with a revenue share of 83.5% in 2023. Horizon Databook has segmented the Australia real time pcr, digital pcr, and end point pcr market based on quantitative, digital, end-point covering the revenue growth of each sub-segment from 2018 to 2030.
Growth in the Australia market can be attributed to the research initiatives being undertaken in collaboration with government organizations and the introduction of new products to diagnose infectious diseases.
Enhanced financial assistance by the government to PCR manufacturers to support the development and commercialization of new diagnostic tests contributes to the uptake of the PCR market in Australia.
In February 2023, Sydney-based venture SpeeDx garnered attention by securing USD 26 million in funding from notable health tech investors, such as Northpond Ventures, Platinum Asset Management, and Tenmile, a health tech fund associated with Andrew ‘Twiggy’ Forrest and his wife Nicola’s private investment vehicle Tattarang.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia real time pcr, digital pcr, and end point pcr market , including forecasts for subscribers. This country databook contains high-level insights into Australia real time pcr, digital pcr, and end point pcr market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account